Streetbeat News

Stock Prices

GURE

MGIH

NTIC

SBSW

UAMY

The article lists the top 5 oversold materials stocks with potential for growth in November, based on their low Relative Strength Index (RSI) values. United States Antimony Corporation (UAMY), Northern Technologies International Corporation (NTIC), Gulf Resources, Inc. (GURE), Millennium Group International Holdings Limited (MGIH), and Sibanye Stillwater Limited (SBSW) are identified as major oversold players in the sector, with RSI values near or below 30, indicating they may be undervalued.

Portfolio Pulse from Lisa Levin

November 22, 2023 | 1:14 pm

TLRY

Tilray Brands, Inc. has launched Redecan's new Redees 'Hemp'd' pre-rolls, featuring sustainable hemp paper and patented filter tips. The product expansion follows the introduction of exclusive cannabis strains in September. The Hemp'd line also includes festive 'Stocking Stuffers' with new genetics. Tilray's shares saw a slight increase in pre-market trading.

Portfolio Pulse from Jelena Martinovic

November 22, 2023 | 1:14 pm

MTEK

Maris-Tech announced receiving a new order worth $550,000 from a defense industry company for its Jupiter AI platform-based intelligence-gathering situational awareness solution, to be used in armored and autonomous vehicles.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 1:11 pm

ANGH

CUEN

DRCT

GDC

GPAK

GROM

MNY

TGL

TRMR

In Wednesday's pre-market session, Grom Social Enterprises (GROM), Tremor Intl (TRMR), and GD Culture Group (GDC) experienced stock price gains, while Anghami (ANGH), Gamer Pakistan (GPAK), Treasure Global (TGL), MoneyHero (MNY), Cuentas (CUEN), and Direct Digital Holdings (DRCT) saw their stock prices fall. Tremor Intl released Q3 earnings today, and Cuentas released Q3 earnings two days ago.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 1:06 pm

AFIB

APLM

ATHE

CRIS

HSCS

NMTC

NXL

PXMD

SILO

TCBP

TCON

UPH

In Wednesday's pre-market session, several healthcare stocks experienced significant movements. Heart Test Laboratories, PaxMedica, NeuroOne Medical Tech, Apollomics, TC BioPharm, and Curis saw their stocks rise by 23.9%, 23.24%, 14.68%, 14.18%, 13.99%, and 12.32% respectively. Conversely, UpHealth, Alterity Therapeutics, Nexalin Technology, SILO Pharma, Acutus Medical, and TRACON Pharma faced declines of 20.2%, 15.97%, 15.52%, 11.96%, 10.44%, and 10.05% respectively.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 1:06 pm

ELWS

SPCE

VINO

In Wednesday's pre-market session, several industrial stocks showed significant movement. Earlyworks Co (ELWS) and Gaucho Group Holdings (VINO) were among the gainers, with ELWS rising 23.3% and VINO up 6.53%. Dragonfly Energy Hldgs (DFLI), Sidus Space (SIDU), Babcock & Wilcox (BW), and Falcons Beyond Global (FBYD) also saw gains. On the losing side, Emeren Group (SOL) and Deere (DE) experienced declines of 17.6% and 5.73%, respectively, following their earnings reports. Mesa Air Gr (MESA), Virgin Galactic Hldgs (SPCE), Safe & Green Holdings (SGBX), and C3is (CISS) also saw their stock prices drop.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 1:06 pm

ADSK

AGIL

DATS

EGIO

MMAT

PBTS

In Wednesday's pre-market session, several IT stocks showed significant movement. AgileThought (AGIL) saw a substantial increase of 64.6%, while Edgio (EGIO) and DatChat (DATS) also experienced notable gains. Conversely, Meta Materials (MMAT), Powerbridge Technologies (PBTS), and Autodesk (ADSK) were among the stocks that declined, with Autodesk's drop following its Q3 earnings release.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 1:06 pm

USO

OPEC+ is set to proceed with its meeting on Sunday as scheduled, according to Reuters citing Ria. The outcome of this meeting could influence global oil supply and prices.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 1:02 pm

Dollar General (NYSE:DG) has received 29 analyst ratings in the last quarter with an average price target of $135.03, which is higher than its current price of $123.49. The current average price target has decreased by 17.88% from the previous target of $164.43. The ratings include 3 bullish, 4 somewhat bullish, 20 indifferent, 2 somewhat bearish, and 0 bearish.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 1:01 pm

SOL

Over the last 3 months, 5 Wall Street analysts have provided ratings on Emeren Group (NYSE:SOL), with 4 giving bullish and 1 somewhat bullish opinions. The average 12-month price target for SOL is $7.6, with a high of $10.00 and a low of $6.00. This target is a 24.75% decrease from the previous target of $10.10. Analysts' ratings are based on predictions of a company's future earnings and revenue, and are updated quarterly or after major company events.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 1:00 pm